UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD/ LU0069152568 /
| NAV2024-05-17 | Chg.-2.9500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 707.9900USD | -0.41% | reinvestment | Equity Worldwide | UBS Fund M. (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1996 | - | - | - | - | - | - | - | - | - | - | -4.08 | 8.59 | - |
| 1997 | 10.23 | -1.37 | -12.78 | -3.24 | 11.00 | 0.99 | 2.77 | 3.38 | 15.45 | -4.22 | -3.25 | -3.86 | +12.39% |
| 1998 | -3.18 | 4.75 | 7.03 | 2.78 | -4.73 | 1.03 | -3.98 | -21.12 | 14.65 | 5.23 | 7.50 | 7.30 | +13.19% |
| 1999 | 8.41 | -7.98 | -0.26 | -5.91 | 6.72 | 7.69 | 6.90 | 8.22 | -8.48 | 0.18 | 6.52 | 30.26 | +58.33% |
| 2000 | 14.96 | 41.13 | -28.27 | -8.94 | -4.27 | 31.61 | -6.41 | 20.88 | 0.84 | -7.51 | -15.77 | 6.43 | +26.30% |
| 2001 | -11.88 | -5.24 | -19.46 | 13.22 | 4.40 | 2.85 | -11.46 | 0.20 | -12.70 | 13.76 | 7.79 | -2.24 | -24.10% |
| 2002 | -13.60 | -6.28 | 3.21 | -14.39 | -10.11 | -13.84 | 2.73 | -5.61 | -5.36 | 8.14 | 7.57 | -11.60 | -47.69% |
| 2003 | -3.18 | -1.77 | 4.81 | 7.49 | 15.57 | -3.30 | 11.62 | 0.97 | -3.32 | -0.52 | 0.17 | 3.77 | +34.94% |
| 2004 | 6.35 | 0.73 | 0.68 | 2.96 | -3.19 | -1.79 | -10.15 | -0.06 | 4.18 | -3.94 | 2.77 | 7.94 | +5.24% |
| 2005 | -5.75 | -6.14 | -6.85 | -0.67 | 2.85 | 2.04 | 12.27 | 2.28 | 0.31 | -5.00 | 5.46 | 3.82 | +2.92% |
| 2006 | 3.38 | 4.40 | -2.11 | -6.24 | -6.02 | 0.32 | -1.16 | 2.34 | 1.01 | 8.17 | -0.45 | -2.90 | -0.21% |
| 2007 | 1.70 | -1.89 | -0.67 | 8.05 | -0.01 | -5.25 | -2.25 | 5.69 | 4.85 | 2.15 | -1.93 | -4.83 | +4.78% |
| 2008 | -3.27 | -4.34 | 0.96 | 0.89 | 4.52 | -1.16 | 17.71 | -5.19 | -6.71 | -11.52 | -9.04 | 10.57 | -9.78% |
| 2009 | -1.06 | -9.83 | 5.49 | -0.09 | 1.98 | 9.13 | 11.32 | -0.45 | 1.53 | -11.08 | 7.86 | 3.96 | +17.40% |
| 2010 | 3.91 | 1.85 | 7.90 | -0.85 | -11.79 | -4.93 | 7.69 | -1.88 | 11.30 | -0.53 | -2.62 | 5.68 | +14.32% |
| 2011 | -0.88 | 1.46 | 7.18 | 6.85 | 1.41 | -4.56 | -2.97 | -10.14 | -3.14 | 7.25 | -1.54 | 2.44 | +1.85% |
| 2012 | 9.72 | -0.26 | 4.55 | 4.85 | -1.98 | 5.75 | 4.90 | 1.52 | 6.88 | -8.14 | 4.43 | -2.25 | +32.71% |
| 2013 | 7.82 | 1.36 | 8.98 | 7.78 | 4.49 | -5.35 | 15.66 | -2.92 | 5.81 | -4.58 | 8.35 | -0.83 | +54.62% |
| 2014 | 14.26 | 6.78 | -11.06 | -5.46 | 3.54 | 6.82 | 1.26 | 13.19 | -2.34 | 8.40 | 2.65 | -0.03 | +41.28% |
| 2015 | 7.11 | 4.81 | 1.44 | -5.66 | 9.36 | -0.51 | 1.80 | -11.57 | -11.56 | 8.37 | 2.47 | -1.71 | +1.57% |
| 2016 | -21.18 | -4.52 | 4.31 | 5.16 | 3.27 | -7.16 | 12.18 | -2.49 | 3.60 | -12.31 | 8.49 | -2.83 | -17.08% |
| 2017 | 6.27 | 8.25 | -0.69 | 2.18 | -4.40 | 9.86 | 3.77 | 4.70 | -0.21 | -6.89 | -0.31 | 1.68 | +25.45% |
| 2018 | 5.71 | -5.26 | -3.10 | -2.78 | 4.87 | 2.42 | 2.97 | 4.44 | -2.08 | -13.55 | 5.61 | -9.74 | -12.05% |
| 2019 | 14.95 | 2.52 | -0.95 | -5.70 | -5.12 | 9.12 | -2.94 | -3.27 | -3.77 | 8.44 | 11.14 | 1.74 | +26.26% |
| 2020 | -3.79 | 0.14 | -6.99 | 14.55 | 10.01 | 3.09 | -2.92 | -0.79 | 0.08 | -4.94 | 10.70 | 5.51 | +24.61% |
| 2021 | -0.85 | -3.31 | -2.99 | 2.18 | -1.47 | 9.09 | -1.56 | 5.14 | -6.32 | -3.03 | -4.24 | 2.61 | -5.63% |
| 2022 | -11.66 | -2.71 | 4.10 | -9.90 | -3.91 | 5.86 | 1.43 | 5.19 | -0.31 | 4.72 | 6.94 | -6.14 | -8.31% |
| 2023 | 1.32 | -6.03 | 0.80 | 0.63 | -2.75 | 1.04 | 2.67 | -2.00 | -4.14 | -8.90 | 5.02 | 15.82 | +1.44% |
| 2024 | -2.87 | -0.65 | 1.77 | -8.43 | 9.79 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.44% | 21.02% | 19.40% | 22.12% | 23.98% |
| Sharpe ratio | -0.37 | 1.49 | -0.02 | -0.27 | 0.04 |
| Best month | +15.82% | +15.82% | +15.82% | +15.82% | +15.82% |
| Worst month | -8.43% | -8.43% | -8.90% | -11.66% | -11.66% |
| Maximum loss | -15.39% | -15.39% | -17.46% | -36.37% | -36.37% |
| Outperformance | -2.88% | - | -7.11% | -9.65% | -15.47% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| UBS(Lux)E.F.-Biotech(USD)P a.SEK | reinvestment | 968.3600 | +5.80% | +20.28% | |
| UBS(Lux)E.F.-Biotech(USD)QL a.US... | reinvestment | 101.9800 | +4.73% | -2.82% | |
| UBS(Lux)E.F.-Biotech(USD)Q a.USD | reinvestment | 313.6700 | +4.52% | -3.40% | |
| UBS (Lux) Equity Fund - Biotech ... | reinvestment | 99.4900 | +3.98% | - | |
| UBS (Lux) Equity Fund - Biotech ... | reinvestment | 707.9900 | +3.46% | -6.32% |
Performance
| YTD | -1.27% | ||
|---|---|---|---|
| 6 Months | +16.09% | ||
| 1 Year | +3.46% | ||
| 3 Years | -6.32% | ||
| 5 Years | +26.41% | ||
| 10 Years | +73.56% | ||
| Since start | +607.99% | ||
| Year | |||
| 2023 | +1.44% | ||
| 2022 | -8.31% | ||
| 2021 | -5.63% | ||
| 2020 | +24.61% | ||
| 2019 | +26.26% | ||
| 2018 | -12.05% | ||
| 2017 | +25.45% | ||
| 2016 | -17.08% | ||
| 2015 | +1.57% | ||
